]>
IRCT20200420047141N1 IRCT 2020-04-24 Ahvaz University of Medical Sciences Evaluation of the effect of vitamin D3 supplementation in doses of 1000 and 3000 IU / day on hyperglycemic control, wound healing,wound infection and sepsis incidence and length of stay in hospital in burn patients Evaluation of the effect of vitamin D3 supplementation in doses of 1000 and 3000 IU / day on hyperglycemic control, wound healing,wound infection and sepsis incidence and length of stay in hospital in burn patients 2020-04-23 anticipated 54 Complete https://irct.ir/trial/47310 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: Https://www.sealedenvelope.com was used to randomly enter study participants. With the help of this site, for 54 participants in three defined groups A (group receiving 3000 IU of vitamin D daily), B (group receiving 1000 IU of vitamin D daily) and C (control group), the random order of entry in the study was determined, Blinding description: Participants enter the study with a personal satisfaction form and all study cases are explained to them. However, he does not know in which group and for what purpose he entered. Before starting the study, the patient will be told that he or she will not be provided with any information. N/A Burn patients. Intervention 1: Intervention group:The first group receives a dose of 1000IU vitamin D from Flexan on a daily basis and orally from the time of admission until discharge from the hospital. Intervention 2: Intervention group: The second group receives a dose of 3000IU vitamin D from Flexan on a daily basis and orally from the time of admission until discharge from the hospital. (To access this dose, each patient will receive a 1000IU perl and a 2000IU perl per day.). Intervention 3: Control group: No supplements. No - There is not a plan to make this available Justification or reason for not sharing IPD is Due to the financial support of this research project carried out by Ahwaz Jundishapur University of Medical Sciences, it will be allowed to publish study data in the form of an article after the end of the intervention.
public Elaheh Ghadimi
Gulestan, Arian1 Building
Ahvaz Iran (Islamic Republic of) 6136753591 +98 61 3337 1272 ghadimi.elaheh1996@gmail.com Ahvaz University of Medical Sciences scientific Anahita Mansoori
Nutrition Department, Ahvaz Jundishapur University of Medical Science, Golestan highway
Ahvaz Iran (Islamic Republic of) 6135715794 +98 61 3336 2414 mansoori-a@ajums.ac.ir Ahvaz University of Medical Sciences Iran (Islamic Republic of) Age group 50_18 years Burns 50-20% Second and third degree burns At least two weeks in the hospital according to the doctor's prognosis Satisfaction of the individual Absence of chronic diseases such as diabetes and high blood pressure and chronic kidney disease No supplement with Vit D in the last 6 months Lack of disorders such as hypoparathyroidism, hyperthyroidism, tumors and bone disease Not receiving sex hormones to treat osteoporosis Patient awareness and ability to answer questionnaire questions Able to receive oral vitamin 18 years 50 years Both Diagnosis of the relevant physician and discretion to discontinue the supplement due to clinical problems created in the patient The patient's reluctance to continue studying Reduce awareness and ability to answer questionnaire questions The patient's death T30-2, T30 Burn of second degree, body region unspecified, Burn of third degree, body region unspecified Prevention Prevention Prevention Intervention group:The first group receives a dose of 1000IU vitamin D from Flexan on a daily basis and orally from the time of admission until discharge from the hospital. Intervention group: The second group receives a dose of 3000IU vitamin D from Flexan on a daily basis and orally from the time of admission until discharge from the hospital. (To access this dose, each patient will receive a 1000IU perl and a 2000IU perl per day.) Control group: No supplements Hyperglycemic control. Timepoint: At least twice a week. Method of measurement: Blood sampling in fasting mode. Wound healing. Timepoint: Before the start of the intervention, 7 days and 14 days after the intervention. Method of measurement: Bates-jensenWound assessment tool. Infection of the wound and sepsis. Timepoint: On the fifth day of hospitalization. Method of measurement: Biopsy of wound depth and blood culture. The length of hospitalisation. Timepoint: From admission to discharge. Method of measurement: Count the number hospitalisation days. Ahvaz University of Medical Sciences Approved 2020-02-24 Ethics committee of Jundishapur university of Medical Sciences Golestan street, Arian1 building Ahvaz Khouzestan Iran (Islamic Republic of)